共有 50 笔近期内部人交易记录记录，涉及 Quest Diagnostics Incorporated (DGX), 包括 11 笔买入 和 33 笔卖出. 内部人买入总额为 $27.15M 内部人卖出总额为 $28.42M.
近期活跃的重要内部人包括 Wentworth Timothy C, Prevoznik Michael E, Plewman Patrick. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — DGX
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-04-01 |
Wentworth Timothy C |
Director |
限制性股票授予 (RSU) |
198 |
- |
- |
198 |
| 2026-03-09 |
Wentworth Timothy C |
Director |
未知 |
- |
- |
- |
- |
| 2026-03-09 |
Wentworth Timothy C |
Director |
限制性股票授予 (RSU) |
215 |
- |
- |
215 |
| 2026-03-05 |
Prevoznik Michael E |
SVP & General Counsel |
知情卖出 |
3,878 |
$206.21 |
$799.68K |
37,557 |
| 2026-03-05 |
Plewman Patrick |
SVP For Diagnostic Services |
知情卖出 |
2,855 |
$206.21 |
$588.73K |
15,198 |
| 2026-03-05 |
Doherty Catherine T. |
EVP, Regional Businesses |
知情卖出 |
5,558 |
$206.21 |
$1.15M |
67,122 |
| 2026-03-04 |
Prevoznik Michael E |
SVP & General Counsel |
RSU 预扣税 |
3,354 |
$204.86 |
$687.1K |
41,435 |
| 2026-03-04 |
Plewman Patrick |
SVP For Diagnostic Services |
RSU 预扣税 |
2,827 |
$204.86 |
$579.14K |
18,053 |
| 2026-03-04 |
Doherty Catherine T. |
EVP, Regional Businesses |
RSU 预扣税 |
5,806 |
$204.86 |
$1.19M |
72,680 |
| 2026-03-04 |
Davis J. E. |
CEO and President |
RSU 预扣税 |
26,414 |
$204.86 |
$5.41M |
142,423 |
| 2026-03-04 |
Samad Sam |
Executive Vice President & CFO |
RSU 预扣税 |
7,720 |
$204.86 |
$1.58M |
33,268 |
| 2026-03-04 |
Deppe Michael J |
SVP, Corp. Controller & CAO |
RSU 预扣税 |
750 |
$204.86 |
$153.65K |
35,196 |
| 2026-03-04 |
Kuppusamy Karthik |
SVP, Clinical Solutions |
知情卖出 |
2,628 |
$204.86 |
$538.37K |
13,441 |
| 2026-03-04 |
Delaney Mark E |
SVP & Chief Commercial Officer |
RSU 预扣税 |
2,326 |
$204.86 |
$476.5K |
11,864 |
| 2026-03-03 |
Prevoznik Michael E |
SVP & General Counsel |
知情卖出 |
526 |
$207.73 |
$109.27K |
37,557 |
| 2026-03-03 |
Plewman Patrick |
SVP For Diagnostic Services |
知情卖出 |
410 |
$207.73 |
$85.17K |
15,198 |
| 2026-03-03 |
Doherty Catherine T. |
EVP, Regional Businesses |
知情卖出 |
632 |
$207.73 |
$131.29K |
67,122 |
| 2026-03-02 |
Prevoznik Michael E |
SVP & General Counsel |
RSU 预扣税 |
288 |
$204.86 |
$59K |
38,083 |
| 2026-03-02 |
Plewman Patrick |
SVP For Diagnostic Services |
RSU 预扣税 |
230 |
$204.86 |
$47.12K |
15,608 |
| 2026-03-02 |
Doherty Catherine T. |
EVP, Regional Businesses |
RSU 预扣税 |
648 |
$204.86 |
$132.75K |
67,754 |
| 2026-03-02 |
Davis J. E. |
CEO and President |
知情卖出 |
10,000 |
$212.52 |
$2.13M |
117,185 |
| 2026-03-02 |
Samad Sam |
Executive Vice President & CFO |
RSU 预扣税 |
869 |
$204.86 |
$178.02K |
27,041 |
| 2026-03-02 |
Deppe Michael J |
SVP, Corp. Controller & CAO |
RSU 预扣税 |
88 |
$204.86 |
$18.03K |
34,473 |
| 2026-03-02 |
Kuppusamy Karthik |
SVP, Clinical Solutions |
RSU 预扣税 |
205 |
$204.86 |
$42K |
9,869 |
| 2026-03-02 |
Delaney Mark E |
SVP & Chief Commercial Officer |
RSU 预扣税 |
188 |
$204.86 |
$38.51K |
8,508 |
| 2026-02-19 |
Prevoznik Michael E |
SVP & General Counsel |
知情卖出 |
1,111 |
$204.83 |
$227.57K |
38,371 |
| 2026-02-19 |
Plewman Patrick |
SVP For Diagnostic Services |
知情卖出 |
958 |
$204.83 |
$196.23K |
15,838 |
| 2026-02-19 |
Doherty Catherine T. |
EVP, Regional Businesses |
知情卖出 |
1,433 |
$204.83 |
$293.52K |
68,402 |
| 2026-02-18 |
Prevoznik Michael E |
SVP & General Counsel |
限制性股票授予 (RSU) |
9,289 |
$204.96 |
$1.9M |
9,289 |
| 2026-02-18 |
Plewman Patrick |
SVP For Diagnostic Services |
限制性股票授予 (RSU) |
9,009 |
$204.96 |
$1.85M |
9,009 |
| 2026-02-18 |
Doherty Catherine T. |
EVP, Regional Businesses |
限制性股票授予 (RSU) |
13,514 |
$204.96 |
$2.77M |
13,514 |
| 2026-02-18 |
Davis J. E. |
CEO and President |
限制性股票授予 (RSU) |
73,225 |
$204.96 |
$15.01M |
73,225 |
| 2026-02-18 |
Samad Sam |
Executive Vice President & CFO |
限制性股票授予 (RSU) |
18,303 |
$204.96 |
$3.75M |
18,303 |
| 2026-02-18 |
Deppe Michael J |
SVP, Corp. Controller & CAO |
限制性股票授予 (RSU) |
1,688 |
$204.96 |
$345.97K |
1,688 |
| 2026-02-18 |
Kuppusamy Karthik |
SVP, Clinical Solutions |
RSU 预扣税 |
259 |
$206.99 |
$53.61K |
7,914 |
| 2026-02-18 |
Delaney Mark E |
SVP & Chief Commercial Officer |
限制性股票授予 (RSU) |
7,332 |
$204.96 |
$1.5M |
7,332 |
| 2026-02-13 |
Doherty Catherine T. |
EVP, Regional Businesses |
期权行权（卖出） |
26,165 |
$112.17 |
$2.93M |
- |
| 2026-02-10 |
Plewman Patrick |
SVP For Diagnostic Services |
期权行权（卖出） |
5,662 |
$121.81 |
$689.66K |
- |
| 2026-01-28 |
Plewman Patrick |
SVP For Diagnostic Services |
限制性股票授予 (RSU) |
48 |
$183.51 |
$8.81K |
15,381 |
| 2026-01-28 |
Carter Robert B |
Director |
小额交易 |
6 |
$183.51 |
$1.1K |
2,704 |
| 2026-01-28 |
Gregg Vicky B |
Director |
小额交易 |
67 |
$183.51 |
$12.3K |
17,104 |
| 2026-01-28 |
Samad Sam |
Executive Vice President & CFO |
限制性股票授予 (RSU) |
69 |
$183.51 |
$12.66K |
27,910 |
| 2026-01-28 |
Lassiter Wright Iii |
Director |
小额交易 |
7 |
$183.51 |
$1.28K |
9,057 |
| 2026-01-28 |
Kuppusamy Karthik |
SVP, Clinical Solutions |
小额交易 |
16 |
$183.52 |
$2.94K |
10,065 |
| 2026-01-28 |
Delaney Mark E |
SVP & Chief Commercial Officer |
小额交易 |
15 |
$183.51 |
$2.75K |
8,696 |
| 2025-11-25 |
Gregg Vicky B |
Director |
知情卖出 |
1,250 |
$191.76 |
$239.7K |
17,037 |
| 2025-11-25 |
Davis J. E. |
CEO and President |
期权行权（卖出） |
55,093 |
$95.80 |
$5.28M |
- |
| 2025-11-18 |
Delaney Mark E |
SVP & Chief Commercial Officer |
期权行权（卖出） |
7,846 |
$144.47 |
$1.13M |
- |
| 2025-11-05 |
Davis J. E. |
CEO and President |
RSU 预扣税 |
7,143 |
$175.57 |
$1.25M |
120,480 |
| 2025-10-23 |
Pfeiffer Gary M |
Director |
自主卖出 |
4,413 |
- |
- |
- |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
